Oncorus, Inc. announced the appointment of Richard Wanstall as Chief Financial Officer. Mr. Wanstall brings over 25 years of financial and operations experience to Oncorus. Most recently, he served as Chief Financial Officer and Treasurer for Aileron Therapeutics, where he was responsible for overseeing the company's strategy, finance, investor relations, and operations activities.

Prior to Aileron, Mr. Wanstall served as Vice President of Finance at Moderna Therapeutics and as Senior Vice President of Finance at Stream Global Services. Previously, Mr. Wanstall was Vice President of Finance at Art Technology Group, a Vice President at Taxware, and Director of Finance at CNET. He began his career in various financial roles at John Hancock, Fidelity Investments, and PricewaterhouseCoopers.

Mr. Wanstall holds an M.B.A. from Babson College and a B.A. in Accounting from Salem State University.